Filing Details
- Accession Number:
- 0001209191-16-132075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-07 18:38:45
- Reporting Period:
- 2016-07-05
- Filing Date:
- 2016-07-07
- Accepted Time:
- 2016-07-07 18:38:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635590 | W. Thomas Dubensky | C/O Aduro Biotech, Inc. 626 Bancroft Way, 3C Berkeley CA 94710 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-05 | 13,939 | $1.45 | 13,939 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-07-05 | 11,061 | $0.52 | 25,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-07-05 | 25,000 | $11.61 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-07-05 | 13,939 | $0.00 | 13,939 | $1.45 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-07-05 | 11,061 | $0.00 | 11,061 | $0.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 259,576 | 2025-01-09 | No | 4 | M | Direct | |
| 107,191 | 2021-10-23 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2016.
- The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015.
- The shares subject to the Option were fully vested as of December 31, 2015.
Billionaire Hedge Funds
